These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Quantitative image analysis of p53 protein accumulation in keratoacanthomas. Borkowski A; Bennett WP; Jones RT; Borkowski P; Harris CC; Ferreira LR; Kao GF; Trump BF Am J Dermatopathol; 1995 Aug; 17(4):335-8. PubMed ID: 8600795 [TBL] [Abstract][Full Text] [Related]
24. Issues with keratoacanthoma, pseudoepitheliomatous hyperplasia and squamous cell carcinoma within tattoos: a clinical point of view. Kluger N J Cutan Pathol; 2010 Jul; 37(7):812-3. PubMed ID: 19614733 [No Abstract] [Full Text] [Related]
25. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin. Ribeiro D; Narikawa S; Marques ME Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070 [TBL] [Abstract][Full Text] [Related]
27. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma. King DF; Barr RJ J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813 [TBL] [Abstract][Full Text] [Related]
28. Florid keratoacanthomas in a kidney transplant recipient. Case report. Jacobsson S; Linell F; Rausing A Scand J Plast Reconstr Surg; 1974; 8(3):243-6. PubMed ID: 4142109 [No Abstract] [Full Text] [Related]
29. Keratoacanthoma and squamous cell carcinoma of the skin: immunohistochemical localization of involucrin and keratin proteins. Smoller BR; Kwan TH; Said JW; Banks-Schlegel S J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):226-34. PubMed ID: 2419374 [TBL] [Abstract][Full Text] [Related]
30. Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two cases. Newland KM; McCormack CJ; Prince HM; Lade S Australas J Dermatol; 2015 Nov; 56(4):e83-7. PubMed ID: 25330922 [TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma arising in keratoacanthoma: a neglected phenomenon in the elderly. Weedon DD; Malo J; Brooks D; Williamson R Am J Dermatopathol; 2010 Jul; 32(5):423-6. PubMed ID: 20414090 [TBL] [Abstract][Full Text] [Related]
32. Pseudo-epitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma occurring within tattoos: diagnostic issues. Kluger N; Plantier F J Am Acad Dermatol; 2007 Nov; 57(5):901-2. PubMed ID: 17939943 [No Abstract] [Full Text] [Related]
33. Keratoacanthoma: clinical and histopathologic features of regression. Ko CJ; McNiff JM; Bosenberg M; Choate KA J Am Acad Dermatol; 2012 Nov; 67(5):1008-12. PubMed ID: 22521202 [TBL] [Abstract][Full Text] [Related]
35. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study. Soddu S; Di Felice E; Cabras S; Castellanos ME; Atzori L; Faa G; Pilloni L Eur J Histochem; 2013 Feb; 57(1):e6. PubMed ID: 23549465 [TBL] [Abstract][Full Text] [Related]
36. PGP 9.5 expression in cutaneous keratoacanthomas and squamous cell carcinomas. Mastoraki A; Ioannidis E; Patsouris E; Safioleas M; Aroni K Arch Dermatol Res; 2009 Oct; 301(9):653-8. PubMed ID: 19488775 [TBL] [Abstract][Full Text] [Related]
37. Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin. Tataroglu C; Karabacak T; Apa DD Tumori; 2007; 93(3):284-9. PubMed ID: 17679465 [TBL] [Abstract][Full Text] [Related]